Höybye Charlotte, Rähn Tiit
Department of Endocrinology, Karolinska University Hospital, 171 76 Solna, Stockholm, Sweden.
Pituitary. 2009;12(3):211-6. doi: 10.1007/s11102-008-0163-x.
Complete surgical removal of non-functioning pituitary adenomas is often not possible. This retrospective study aimed at evaluating the long-term outcome and complications of Gamma Knife (GK) radiosurgery adjuvant to pituitary microsurgery in selected patients with small tumour remnants treated 1994-2004. Thirteen men and ten women, median age 49 years, were identified. Prior to GK 15 patients had remaining pituitary function. Median size of the tumours was 1.1 cm(3). Median marginal dose was 20 Gy. Median follow-up with MR imaging was 78 and 97 months for clinical evaluation. Tumour growth control was 100%, irrespectively of growth hormone (GH) therapy for 72 months (n = 10). Only one recurrence was discovered outside radiation field and no new hypopituitarism was developed. This report suggests that in well-selected patients the long-term risk of complications is low and with careful surveillance GH insufficiency can be replaced. Lifelong follow-up is mandatory.
完全手术切除无功能性垂体腺瘤通常是不可能的。这项回顾性研究旨在评估1994年至2004年期间,在部分有小肿瘤残留的患者中,伽玛刀(GK)放射外科辅助垂体显微手术的长期疗效和并发症。研究确定了13名男性和10名女性,中位年龄49岁。在进行GK治疗前,15名患者仍保留垂体功能。肿瘤的中位大小为1.1 cm³。中位边缘剂量为20 Gy。采用磁共振成像进行临床评估的中位随访时间分别为78个月和97个月。无论是否接受生长激素(GH)治疗72个月(n = 10),肿瘤生长控制率均为100%。仅在放射野外发现1例复发,且未出现新的垂体功能减退。本报告表明,在精心挑选的患者中,并发症的长期风险较低,通过仔细监测,生长激素缺乏症可以得到替代治疗。必须进行终身随访。